Cargando…

Potential clinical utility of liquid biopsies in ovarian cancer

Ovarian cancer (OC) is the most lethal gynecologic malignancy worldwide. One of the main challenges in the management of OC is the late clinical presentation of disease that results in poor survival. Conventional tissue biopsy methods and serological biomarkers such as CA-125 have limited clinical a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Jie Wei, Charkhchi, Parsa, Akbari, Mohammad R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092780/ https://www.ncbi.nlm.nih.gov/pubmed/35545786 http://dx.doi.org/10.1186/s12943-022-01588-8

Ejemplares similares

What Is Known about Breast Cancer in Young Women?
por: Zhu, Jie Wei, et al.
Publicado: (2023)

CA125 and Ovarian Cancer: A Comprehensive Review
por: Charkhchi, Parsa, et al.
Publicado: (2020)

Genetic susceptibility to hereditary non-medullary thyroid cancer
por: Kamani, Tina, et al.
Publicado: (2022)

Liquid biopsy genotyping in lung cancer: ready for clinical utility?
por: Huang, Wei-Lun, et al.
Publicado: (2017)

Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers
por: Jacobson, Richard A., et al.
Publicado: (2019)

Prostate Cancer Liquid Biopsy Biomarkers’ Clinical Utility in Diagnosis and Prognosis
por: Matuszczak, Milena, et al.
Publicado: (2021)

Translational Utility of Liquid Biopsies in Thyroid Cancer Management
por: Wijewardene, Ayanthi A., et al.
Publicado: (2021)

Potential utility of miRNAs for liquid biopsy in breast cancer
por: Liu, Xiangrong, et al.
Publicado: (2022)

The new horizon of liquid biopsy in sarcoma: the potential utility of circulating tumor nucleic acids
por: Wei, Junqiang, et al.
Publicado: (2020)

The Utility of Repetitive Cell-Free DNA in Cancer Liquid Biopsies
por: Gezer, Ugur, et al.
Publicado: (2022)

Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer
por: Shen, Haifeng, et al.
Publicado: (2022)

Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review
por: Nigro, Maria Concetta, et al.
Publicado: (2023)

Methylation Markers in Cutaneous Melanoma: Unravelling the Potential Utility of Their Tracking by Liquid Biopsy
por: Aleotti, Valentina, et al.
Publicado: (2021)

The potential of liquid biopsies for the early detection of cancer
por: Heitzer, Ellen, et al.
Publicado: (2017)

Liquid Biopsy in Colorectal Cancer-Current Status and Potential Clinical Applications
por: Norcic, Gregor
Publicado: (2018)

Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes
por: Feeney, Laura, et al.
Publicado: (2020)

Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression
por: Chang, Lei, et al.
Publicado: (2019)

Liquid biopsy for lung cancer immunotherapy
por: Cai, Liang-Liang, et al.
Publicado: (2019)

The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management
por: Keup, Corinna, et al.
Publicado: (2023)

Liquid biopsies for cancer: From bench to clinic
por: Chen, Zhenhui, et al.
Publicado: (2023)

Clinical utility of liquid biopsy-based companion diagnostics in the non-small-cell lung cancer treatment
por: Sato, Yoshiharu
Publicado: (2022)

Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR
por: Palacín-Aliana, Irina, et al.
Publicado: (2021)

Clinical utility of liquid biopsy for the diagnosis and monitoring of EML4-ALK NSCLC patients
por: Sánchez-Herrero, Estela, et al.
Publicado: (2020)

The liquid biopsy in lung cancer
por: Ansari, Junaid, et al.
Publicado: (2016)

Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer—Current Use and Future Opportunities
por: Paracchini, Lara, et al.
Publicado: (2021)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

The potential for liquid biopsies in the precision medical treatment of breast cancer
por: Forte, Victoria A., et al.
Publicado: (2016)

Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer
por: Huang, Hai‐Ming, et al.
Publicado: (2020)

The Potential of Aptamer-Mediated Liquid Biopsy for Early Detection of Cancer
por: Roy, Dhruvajyoti, et al.
Publicado: (2021)

Metabolic pathways of potential miRNA biomarkers derived from liquid biopsy in epithelial ovarian cancer
por: Gumusoglu-Acar, Ece, et al.
Publicado: (2023)

Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review
por: Shotton, Rohan, et al.
Publicado: (2021)

Potential utility of risk stratification for multicancer screening with liquid biopsy tests
por: Kim, Elle S., et al.
Publicado: (2023)

Clinical utility of Epstein‐Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma
por: Tan, Rong, et al.
Publicado: (2020)

Liquid Biopsy in Oral Cancer
por: Lousada-Fernandez, Fatima, et al.
Publicado: (2018)

Liquid Biopsy in Gastrointestinal Cancers
por: Saini, Aman, et al.
Publicado: (2018)

Liquid Biopsies in Lung Cancer
por: Kemper, Marcel, et al.
Publicado: (2023)

Liquid Biopsy in Thyroid Cancer: New Insight
por: Khatami, Fatemeh, et al.
Publicado: (2018)

The Significance of Liquid Biopsy in Pancreatic Cancer
por: Qi, Zi-Hao, et al.
Publicado: (2018)

Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology
por: Mathai, Roshni Ann, et al.
Publicado: (2019)

Update on liquid biopsy in clinical management of non-small cell lung cancer
por: Wu, Zhen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_03gbnja0qn881oenmcpip2niob